Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

13.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 14.50
  • 52 Week Low: 5.63
  • Currency: UK Pounds
  • Shares Issued: 444.23m
  • Volume: 106,277
  • Market Cap: £57.75m
  • Beta: 0.03

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

Key Personnel

CEO: Carolyn Cross
CFO and COO: Michael S. Behlke
Chairman: Jean Charest
Chief Technology Officer: Nicolas Loebel
Independent Non-Executive Director: Simon Sinclair
Independent Non-Executive Director: Junaid Bajwa
Interim CFO: Kwong Choo
Senior Independent Non-Executive Director: Jean Duvall
Non-Executive Dir: Craig Tooman

Contact Details

Address: 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Phone: +1 604 669 0555
Website: https://ondinebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: CA68234M2058

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 13.00p
Change Today -0.25p
% Change -1.89 %
52 Week High 14.50
52 Week Low 5.63
Volume 106,277
Shares Issued 444.23m
Market Cap £57.75m
Beta 0.03

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.97% below the market average69.97% below the market average69.97% below the market average69.97% below the market average69.97% below the market average
95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average
Price Trend
33.42% above the market average33.42% above the market average33.42% above the market average33.42% above the market average33.42% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Income Not Available
Growth
41.26% above the market average41.26% above the market average41.26% above the market average41.26% above the market average41.26% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average

OBI Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:21 50,000 @ 13.35p
14:46 1,000 @ 12.59p
12:57 1,150 @ 13.50p
12:57 15,342 @ 13.08p
10:38 18,000 @ 13.19p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page